Article

FDA Issues Comprehensive List of Guidance Documents

Author(s):

BioPharm International Editors

28 JUNE - Comprehensive List of Guidance Documents http://www.fda.gov/cder/guidance/guidlist.pdf

FDA has issued a Comprehensive List of Guidance Documents, available at:www.fda.gov/cder/guidance/guidlist.pdf

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 9th 2025

Celltrion Gains Expanded Indication Approval from FDA for its Actemra Biosimilar for CRS Therapy

Feliza Mirasol
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 9th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
August 9th 2025

Next for Biopharma: Speed, Strategy, and Smarter Systems

Mike Hennessy Jr.
Mastering Antibody-Drug Conjugates
August 9th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 9th 2025

FDA Accepts Breyanzi sBLA from Bristol Myers Squibb and Grants It Priority Review for MZL

Feliza Mirasol
Doctor or scientist shows a vial of genetic agent as a vaccine or therapy against Corona or Covid-19 as a symbolic image | Image Credit: © Dan Race - stock.adobe.com
August 9th 2025

Reaction and Fallout as HHS ‘Winds Down’ mRNA Vaccine Development, Canceling $500 Million in Projects

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.